Skip to main content
Realcan Pharmaceutical Group Co.,Ltd. logo

Realcan Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 002589 ISIN · CNE1000013X5 LEI · 300300YI5IV3FBRRSJ48 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,678 across all filing types
Latest filing 2024-04-29 AGM Information
Country CN China
Listing Shenzhen Stock Exchange 002589

About Realcan Pharmaceutical Group Co.,Ltd.

https://www.realcan.cn

Realcan Pharmaceutical Group Co., Ltd. specializes in the distribution of pharmaceutical products, medical devices, and healthcare consumables. The company operates an extensive supply chain network, providing integrated logistics and distribution services primarily to medical institutions and healthcare providers. Its core operations include the procurement, storage, and delivery of a wide range of medical supplies, supported by advanced information management systems and cold-chain logistics capabilities. Realcan also offers value-added services such as hospital supply chain optimization, third-party logistics, and financial solutions tailored to the healthcare industry. By focusing on a direct-to-hospital distribution model, the company aims to enhance the efficiency of medical supply procurement and ensure the timely delivery of critical healthcare products.

Recent filings

Filing Released Lang Actions
年度股东大会通知
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2023 Annual General Meeting (AGM) of 瑞康医药集团股份有限公司. It includes information about the meeting date, location, voting procedures (both in-person and online), agenda items to be voted on, and instructions for shareholders to participate. It also contains an authorization proxy form for shareholders who cannot attend. The document does not contain the actual annual report, financial statements, or voting results, but rather the announcement and procedural details for the AGM. The document length is 4560 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2024-04-29 Chinese
2023年年度报告
Annual Report Classification · 100% confidence The document is titled as the "2023 年年度报告全文" which translates to "2023 Annual Report Full Text". It contains detailed sections typical of an annual report such as company overview, financial data, management discussion and analysis, corporate governance, environmental and social responsibility, important matters, shareholder information, bond information, and financial statements. The document includes comprehensive financial figures, management commentary, and audit information. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The presence of audit report references and detailed financial data confirms it is the official annual report. Therefore, the document fits the definition of an Annual Report (10-K). FY 2023
2024-04-29 Chinese
关于举办2023年度网上业绩说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement by 瑞康医药集团股份有限公司 about holding a 2023 annual performance explanation meeting (业绩说明会). It references that the 2023 annual report has already been disclosed on April 30, 2024, and the meeting is scheduled for May 8, 2024. The document invites investors to participate in the online meeting and submit questions. The content is primarily about the scheduling and format of an investor presentation event related to the annual results, not the report itself. The document length is short (1055 characters) and it does not contain financial data or detailed analysis. Therefore, it is best classified as an Investor Presentation (IP) announcement or notice rather than the full Annual Report (10-K) or a Report Publication Announcement (RPA). Given the detailed description of the event and the invitation to investors, the classification as Investor Presentation (IP) is most appropriate.
2024-04-29 Chinese
关于提前终止实施2022年度员工持股计划的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from 瑞康医药集团股份有限公司 regarding the early termination of the 2022 employee stock ownership plan. It details the board and committee meetings, approvals, and reasons for termination. The document is a formal announcement about a corporate action related to employee stock plans, not a financial report, earnings release, or regulatory certification. It does not contain financial statements or detailed financial data. It is also not a proxy solicitation or voting result announcement. The content fits best under a Regulatory Filing (RNS) as it is a formal disclosure of a corporate governance event that does not fit other specific categories.
2024-04-29 Chinese
内部控制审计报告
Audit Report / Information Classification · 95% confidence The document is titled as an "Internal Control Audit Report" issued by a certified public accounting firm for 瑞康医药集团股份有限公司. It references auditing standards and provides an opinion on the effectiveness of internal controls over financial reporting as of December 31, 2023. The content is focused on audit procedures and conclusions rather than a full annual report or financial statements. The document length is 1124 characters, which is relatively short but contains substantive audit opinion content. This matches the definition of an Audit Report / Information (AR) rather than a full Annual Report (10-K) or a simple announcement. Therefore, the document is classified as an Audit Report / Information (AR). FY 2023
2024-04-29 Chinese
独立董事述职报告（武滨）
Board/Management Information Classification · 95% confidence The document is an independent director's annual performance report for the year 2023, detailing the director's activities, opinions, attendance, and contributions to the board and company governance. It is a formal report by an individual director rather than a company-wide annual report or financial statement. It does not contain financial data or audit results but focuses on governance and director duties. This fits best under Board/Management Information (MANG), which includes announcements or reports related to board members' activities and management information.
2024-04-29 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.